CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim
CVRx, Inc. (CVRX)
Company Research
Source: GlobeNewswire
MINNEAPOLIS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today the presentation of new real-world evidence at the Technology and Heart Failure Therapeutics (THT) conference in Boston. The study demonstrated large and statistically significant reductions in hospital visits (hospitalizations and emergency department visits) and length of stay after Barostim implantation, compared to before. The research was published simultaneously and is available now in the Journal of Cardiac Failure. “Despite contemporary medications, the clinical and economic burden of heart failure remains unacceptably high. This new study showing significant reductions i
Read more
Impact Snapshot
Event Time:
CVRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVRX alerts
High impacting CVRx, Inc. news events
Weekly update
A roundup of the hottest topics
CVRX
News
- Several Insiders Invested In CVRx Flagging Positive News [Yahoo! Finance]Yahoo! Finance
- CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim [Yahoo! Finance]Yahoo! Finance
- CVRx Inc (CVRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Expenses [Yahoo! Finance]Yahoo! Finance
- CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Piper Sandler from $16.00 to $20.00. They now have an "overweight" rating on the stock.MarketBeat
- CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $22.00 to $23.00. They now have a "buy" rating on the stock.MarketBeat
CVRX
Earnings
- 2/4/25 - Miss
CVRX
Sec Filings
- 3/4/25 - Form 4
- 3/4/25 - Form 4
- 3/4/25 - Form 4
- CVRX's page on the SEC website